Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Osteoporosis Reports
Published in: Current Osteoporosis Reports 4/2014

01-12-2014 | Therapeutics and Medical Management (E Shane and RA Adler, Section Editors)

Calcium Use in the Management of Osteoporosis: Continuing Questions and Controversies

Authors: Cory Wilczynski, Pauline Camacho

Published in: Current Osteoporosis Reports | Issue 4/2014

Login to get access

Abstract

Calcium is a vital element in the health and maintenance of growing and mature bone. The amount of calcium recommended for ingestion varies by age, and these requirements can be met by dietary sources or calcium supplementation. This article reviews the role of calcium in the body and the benefits and risks to calcium supplementation. The effects of calcium on fracture risk reduction, bone density, and bone turnover markers as well as the conflicting data on cardiovascular events and increased risk of nephrolithiasis associated with supplementation are discussed.
Literature
1.
Asomaning K, Bertone-Johnson ER, Nasca PC, Hooven F, Pekow PS. The association between body mass index and osteoporosis in patients referred for a bone mineral density examination. J Womens Health. 2006;15(9):1028–34.CrossRef
2.•
Moyer VA, Lefevre ML, Siu AL. Vitamin D and calcium supplementation to prevent fractures in adults. Ann Int Med. 2013;159(12):856–7. Available at: http://​www.​uspreventiveserv​icestaskforce.​org/​uspstf12/​vitamind/​finalrecvitd.​htm. This is the USPTF recommendations for calcium and vitamin D use in osteoporosis treatment. Previous recommendations had no question of calcium use in the management of osteoporosis but the new guidelines, given recent articles coming out about cardiovascular event association with supplementation use, have brought use of calcium supplementation into question. Accessed 14 Apr 2014.
3.
4.
5.
6.•
Booth A, Camacho P. A closer look at calcium absorption and the benefits and risks of dietary vs supplemental calcium. Postgrad Med J. 2013;125(6):73–81. Booth and Camacho’s article directly reviews the difference between calcium supplementation and dietary calcium intake. The benefits of dietary supplementation are evident as well as a review of where calcium is absorbed in the gastrointestinal tract. This was a good source for comparing dietary vs supplement intake.CrossRef
7.
Rafferty K, Walters G, Heaney RP. Calcium fortifications: overview and strategies for improving calcium nutrients of the U.S. population. J Food Sci. 2007;72(9):R152–8.PubMedCrossRef
8.
Christodoulu C, Cooper C. What is osteoporosis? Postgrad Med J. 2003;79:133–8.CrossRef
9.
10.
Cummings RJ, Nevitt MC. Calcium for prevention of osteoporotic fractures in postmenopausal women. J Bone Miner Res. 1997;12(9):1321–9.CrossRef
11.
Chevalley T, Rizzoli R, Nydegger V, et al. Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients. Osteoporosis Int. 1994;4(5):245–52.CrossRef
12.
Cumming RG. Calcium intake and bone mass: a quantitative review of the evidence. Calcif Tissue Int. 1990;47(4):194–201.PubMedCrossRef
13.
Shea B, Wells G, Cranney A, et al. Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev. 2002;23(4):552–9.PubMedCrossRef
14.
15.
16.
Dawson-Hughes B, Harris S, Krall E, et al. Effects of calcium and vitamin d supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337(10):670–6.PubMedCrossRef
17.
Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J. Vitamin D and calcium: a systemic review of Health Outcomes. Evidence report/technology assessment no. 183. Rockville, MD: Agency for Healthcare Research and Quality; 2009. Available at: www.​ncbi.​nlm.​nih.​gov/​books/​NBK32603/​. Accessed 12 Jun 2014.
18.
Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer fractures: an updated meta-analysis for the US Preventative Services Task Force. Ann Intern Med. 2011;155:827–38.PubMedCrossRef
19.
20.
Prince RL, Devine A, Dhaliwal SS, Dick IM. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med. 2006;166:869–75.PubMedCrossRef
21.
Peacock M, Liu G, Carey M, et al. Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab. 2000;85:3011–9.PubMed
22.
Harwood R, Sahota O, Gaynor K, Masud T, Hosking D. A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: the Nottingham Neck of Femur (NoNOF) Study. Age Ageing. 2004;33:45–51.PubMedCrossRef
23.
Larsen ER, Mosekilde L, Foldsprang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res. 2004;19:370–8.PubMedCrossRef
24.
Reid I, Mason B, Horne A, et al. Randomized controlled trial of calcium in healthy older women. Am J Med. 2006;119:777–85.PubMedCrossRef
25.
Riggs BL, O’Fallon WM, Muhs J, et al. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res. 1998;13(2):168–74.PubMedCrossRef
26.
27.
Sambrook P, Birmingham R, Kelly P, et al. Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol, and calcitonin. N Engl J Med. 1993;328(24):1747–52.PubMedCrossRef
28.
Maalouf N, Heller H, Odvina C, Kim P, Sakhaee K. Bisphosphonate-induced hypocalcemia: report of 3 cases and review of the literature. Endocr Prac. 2006;12(1):48–53.CrossRef
29.
Rosen CJ. Letter-Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. N Engl J Med. 2003;348(15):1503–4.PubMedCrossRef
30.
Talreja DB. Severe hypocalcemia following a single injection of denosumab in a patient with renal impairment. J Drug Assess. 2012;1:30–3.CrossRef
31.
Chennuru S, Koduri J, Baumann MA. Risk factors for hypocalcemia complicating treatment with zoledronic acid. Intern Med J. 2008;38:635–7.PubMedCrossRef
32.
Lips P, Bouillon R, van Schoor NM, et al. Reducing fracture risk with calcium and vitamin D. Clin Endocrinol. 2010;73:277–85.CrossRef
33.•
Aloia JF, Dhaliwal R, Shieh A, et al. Calcium and vitamin d supplementation in postmenopausal women. J Clin Endocrinol Metab. 2013;98(11):E1702–9. Calcium supplementation is highlighted as vital in decreasing bone turnover markers. The decreases in bone alkaline phosphatase and c-telopeptide were seen in those using calcium alone as well as those with calcium combined with vitamin D. This shows the importance of adequate calcium levels regardless of vitamin D status in decreasing bone turnover markers.PubMedCrossRef
34.••
Cauley JA, Chlebowshki RT, Wactawski-Wende J, et al. Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women’s Health Initiative. J Womens Health. 2013;22(11):915–29. The results of Cauley et al study is 11 years out, the longest follow-up analysis thus far reported, which showed that there was no significant risk associated with calcium use and CVD. This is a major study that discounts theories that increase plaque deposition is the mechanism of action for increased CVD in supplement users, which has been the proposed mechanism of action of for the link between CVD and calcium supplementation.CrossRef
35.
Jensen C, Holloway L, Block G, et al. Long term effects of nutrient intervention on markers of bone remodeling and calciotropic hormones in late-postmenopausal women. Am J Clin Nutr. 2002;75:1114–20.PubMed
36.
Cummings RG, Cummings SR, Nevitt MC, et al. Calcium intake and fracture risk: results from the study of osteoporotic fractures. Am J Epidemiol. 1997;145(10):926–34.PubMedCrossRef
37.
Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences of idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155:839–43.PubMedCrossRef
38.
Diaz-Lopez B, Cannata-Andia JB. Supplementation of vitamin D and calcium: advantages and risks. Nephrol Dial Transplant. 2006;21:2375–7.PubMedCrossRef
39.
Haghighi A, Samimagham H, Gahardehi G. Calcium and vitamin d supplementation and risk of kidney stone formation in postmenopausal women. Iran J Kidney Dis. 2013;7(3):210–3.PubMed
40.
Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833.PubMedCrossRef
41.
Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk of kidney stones in women. Ann Intern Med. 1997;126:497.PubMedCrossRef
42.
Sakhaee K, Poindexter JR, Griffith CS, Pak CYC. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women. J Urol. 2004;172:958–61.PubMedCrossRef
43.
Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691. Accessed 30 Apr 2014: BMJ.com.
44.
Rautiainen S, Wang L, Manson JE, Sesso HD. The role of calcium in the prevention of cardiovascular disease: a review of observational studies and randomized clinical trials. Curr Atherolscler Rep. 2013;15:362.CrossRef
45.
Paik JM, Curhan GC, Sun Q, et al. Calcium supplement intake and risk of cardiovascular disease in women. Osteoporos Int. 2014;25:2047–56.PubMedCrossRef
46.
Bolland MJ, Barber PA, Doughty RN, Mason B, Horne A, Ames R, et al. Vascular events in healthy older women receiving calcium supplementation: randomized controlled trial. BMJ. 2008;336:262–6.PubMedCrossRefPubMedCentral
47.
Xiao Q, Murphy RA, Houston DK, Harris TB, Chow WH, Park Y. Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med. 2013;173:639–46.PubMedCrossRefPubMedCentral
48.
Van Hemelrijck M, Michaelsson K, Linseisen J, Rohrmann S. Calcium intake and serum concentration in relation to risk of cardiovascular death in NHANES III. PLoS One. 2013;8(4):e61037.PubMedCrossRefPubMedCentral
49.
Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med. 1999;340:101–7.PubMedCrossRef
50.
Downing L, Islam MA. Influence of calcium supplements on the occurrence of cardiovascular events. Am J Health Syst Pharm. 2013;70(13):1132–9.PubMedCrossRef
51.
Lewis J, Rejnmark L, Ivey K, Prentice R, Prince R. The cardiovascular safety of calcium supplementation with or without vitamin D in elderly women: a collaborative meta-analysis of published and unpublished trial level evidence from randomized controlled trials. J Bone Miner Res. 2013;28:1002.
52.
Ebeling P, English D, Nowson C, Daly R, Khan B. Long term effects of higher dietary calcium intake on vertebral fractures and severe abdominal aortic calcification in older Australians. J Bone Miner Res. 2013;28:S492.
53.
Bauer D, Harrison S, Cawthorn P, Barrett-Connor E, Shikany J, Ensrud K, et al. Dietary and supplemental calcium intake and the risk of mortality in older men: the MrOS study. J Bone Miner Res. 2013;28:1001.
54.
Bostick RM, Kushi LH, Wu Y, Meyer KA, Sellers TA, Folsom AR. Relation of calcium, vitamin D, and diary food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol. 1999;149:151–61.PubMedCrossRef
55.
Iso H, Stampfer MJ, Manson JE, et al. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke. 1999;30:1772–9.PubMedCrossRef
56.
Al-Delaimy WK, Rimm E, Willett WC, et al. A prospective study of calcium intake from diet and supplements and risk of ischemic heart disease among men. Am J Clin Nutr. 2003;77:814–8.PubMed
57.
National Osteoporosis Foundation responds to the U.S. Preventive Services Task Force recommendations on Calcium and Vitamin D. National Osteoporosis Foundation. 2013 Feb. http://​nof.​org/​news/​903. Accessed 16 Apr 2014.
58.
59.
Metadata
Title
Calcium Use in the Management of Osteoporosis: Continuing Questions and Controversies
Authors
Cory Wilczynski
Pauline Camacho
Publication date
01-12-2014
Publisher
Springer US
Published in
Current Osteoporosis Reports / Issue 4/2014
Print ISSN: 1544-1873
Electronic ISSN: 1544-2241
DOI
https://doi.org/10.1007/s11914-014-0234-z

Other articles of this Issue 4/2014

Current Osteoporosis Reports 4/2014 Go to the issue

Skeletal Development (E Schipani and E Zelzer, Section Editors)

Extracellular Matrix and Developing Growth Plate

Imaging (T Lang and F Wehrli, Section Editors)

Vibrational Spectroscopic Imaging for the Evaluation of Matrix and Mineral Chemistry

Imaging (T Lang and F Wehrli, Section Editors)

Micro- and Nano-CT for the Study of Bone Ultrastructure

Skeletal Development (E Schipani and E Zelzer, Section Editors)

Hox Genes and Limb Musculoskeletal Development

Imaging (T Lang and F Wehrli, Section Editors)

Imaging of the Muscle-Bone Relationship

Skeletal Development (E Schipani and E Zelzer, Section Editors)

Osteoblasts: a Novel Source of Erythropoietin